InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Doherty James J., Directeur Digital. Officer active across 1 company, notably Acumen Pharmaceuticals, Inc.. Cumulatively, 3 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €3k. History available since 6 January 2025. The latest transaction was filed on 16 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Doherty James J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
166,867 股0Common StockSEC:0001628280-26-002956:0
1,700 股@ US$1.98790.0018% mcap50.0% 占其流量Common StockSEC:0001628280-26-001636:0
62,600 股0Common StockSEC:0001576885-25-000017:0
3 条申报中的 3 条
About Doherty James J.
James J. Doherty serves as President and Chief Development Officer at Acumen Pharmaceuticals, Inc. He is responsible for the strategic and operational direction of the company, ensuring that growth objectives are met. James has a strong background in the industry, enabling him to effectively lead his teams towards operational excellence. His commitment to innovation and sustainability is central to his mission.
